These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation. Mo C, Zhao R, Vallejo J, Igwe O, Bonewald L, Wetmore L, Brotto M. Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867 [Abstract] [Full Text] [Related]
24. Loading-related regulation of transcription factor EGR2/Krox-20 in bone cells is ERK1/2 protein-mediated and prostaglandin, Wnt signaling pathway-, and insulin-like growth factor-I axis-dependent. Zaman G, Sunters A, Galea GL, Javaheri B, Saxon LK, Moustafa A, Armstrong VJ, Price JS, Lanyon LE. J Biol Chem; 2012 Feb 03; 287(6):3946-62. PubMed ID: 22049075 [Abstract] [Full Text] [Related]
25. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1. Chang HH, Young SH, Sinnett-Smith J, Chou CE, Moro A, Hertzer KM, Hines OJ, Rozengurt E, Eibl G. Am J Physiol Cell Physiol; 2015 Nov 15; 309(10):C639-49. PubMed ID: 26310818 [Abstract] [Full Text] [Related]
26. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. Song FN, Duan M, Liu LZ, Wang ZC, Shi JY, Yang LX, Zhou J, Fan J, Gao Q, Wang XY. PLoS One; 2014 Nov 15; 9(9):e108507. PubMed ID: 25268581 [Abstract] [Full Text] [Related]
27. Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts. Tang CH, Yang RS, Fu WM. J Biol Chem; 2005 Jun 17; 280(24):22907-16. PubMed ID: 15833739 [Abstract] [Full Text] [Related]
28. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C. Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627 [Abstract] [Full Text] [Related]
29. Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway. Wang TP, Hsu SH, Feng HC, Huang RF. Carcinogenesis; 2012 Jun 01; 33(6):1158-68. PubMed ID: 22461522 [Abstract] [Full Text] [Related]
30. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway. Yan L, He Z, Li W, Liu N, Gao S. Cell Cycle; 2021 Sep 01; 20(18):1875-1889. PubMed ID: 34382920 [Abstract] [Full Text] [Related]
31. Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-κB Signaling. Yang Q, Zhang J, Xu S, Jia C, Meng W, Tang H, Zhang X, Zhang Y, Fu B. Biomed Res Int; 2019 Sep 01; 2019():1621854. PubMed ID: 30766880 [Abstract] [Full Text] [Related]
32. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation. Mo SJ, Hou X, Hao XY, Cai JP, Liu X, Chen W, Chen D, Yin XY. Cancer Commun (Lond); 2018 Apr 03; 38(1):9. PubMed ID: 29764501 [Abstract] [Full Text] [Related]
33. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Huang W, Yu D, Wang M, Han Y, Lin J, Wei D, Cai J, Li B, Chen P, Zhang X. Cell Prolif; 2020 Jul 03; 53(7):e12836. PubMed ID: 32537856 [Abstract] [Full Text] [Related]
34. The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation. Theiler A, Konya V, Pasterk L, Maric J, Bärnthaler T, Lanz I, Platzer W, Schuligoi R, Heinemann A. Vascul Pharmacol; 2016 Dec 03; 87():180-189. PubMed ID: 27664754 [Abstract] [Full Text] [Related]
35. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells. Tveteraas IH, Müller KM, Aasrum M, Ødegård J, Dajani O, Guren T, Sandnes D, Christoffersen T. J Exp Clin Cancer Res; 2012 Sep 11; 31(1):72. PubMed ID: 22967907 [Abstract] [Full Text] [Related]
36. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. Yang SF, Chen MK, Hsieh YS, Chung TT, Hsieh YH, Lin CW, Su JL, Tsai MH, Tang CH. J Biol Chem; 2010 Sep 24; 285(39):29808-16. PubMed ID: 20647315 [Abstract] [Full Text] [Related]
37. PGE2 synthesis and signaling in malignant transformation and progression of human hepatocellular carcinoma. Zang S, Ma X, Wu Y, Liu W, Cheng H, Li J, Liu J, Huang A. Hum Pathol; 2017 May 24; 63():120-127. PubMed ID: 28300577 [Abstract] [Full Text] [Related]
38. Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis. Chen X, Yin J, Xu Y, Qiu Z, Liu J, Chen X. Mol Med Rep; 2020 Oct 24; 22(4):2887-2895. PubMed ID: 32700746 [Abstract] [Full Text] [Related]
39. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway. Xing S, Zhang B, Hua R, Tai WC, Zeng Z, Xie B, Huang C, Xue J, Xiong S, Yang J, Liu S, Li H. BMC Cancer; 2015 May 07; 15():368. PubMed ID: 25947641 [Abstract] [Full Text] [Related]
40. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. Han C, Wu T. J Biol Chem; 2005 Jun 24; 280(25):24053-63. PubMed ID: 15855163 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]